For over two decades, the biopharmaceutical manufacturing industry has created a body of industrial knowledge and institutional experience.
This eBook will examine:
- How slow-motion trends are driving biopharma growth
- The dangerous impact of unproven stem cell therapies
- China's biopharma boom: can it continue?